A new Syncona company exploiting the wound healing ability of macrophages to stimulate organ repair following severe injury as a result of chronic disease. Syncona Partners, Ed Hodgkin and Gonzalo Garcia, discuss founding this new company.
- About us
- Our people
- Portfolio
- Sustainability
- News and insights
- Investors
- Contact
